Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Smart Data Management in the Race toward Effective Vaccines

    Jan 20, 2021, 01:00 AM by User Not Found
    Bio-IT World | As vaccines for the novel coronavirus are starting to be rolled out across the world, all eyes are on the scientific community. Demand for novel therapeutics is higher today than ever before and will continue to be in the future. Whether you’re a contract development and manufacturing organization (CDMO) or a vaccine manufacturer, smart data strategy is critical
    Full story
  • Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

    Jan 19, 2021, 11:34 AM by
    Domainex Ltd. has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry to measure target binding and achieves superior resolution to traditional Surface Plasmon Resonance.
    Full story
  • EXTENSIVE LINE OF LIQUID STABLE & READY-TO-USE CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES

    Jan 19, 2021, 11:34 AM by
    VERICHEM LABORATORIES has announced the availability of an extensive line of ready-to-use, liquid stable Clinical Reference Materials intended intended for the calibration and calibration verification of clinical testing systems.
    Full story
  • Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

    Jan 19, 2021, 11:34 AM by
    Full story
  • Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month

    Jan 19, 2021, 11:34 AM by
    Full story
  • MedAI: Explore Therapeutic Antibody Discovery and Development for Disease Treatment

    Jan 19, 2021, 11:34 AM by
    Full story
  • Organocatalysts Available at Alfa Chemistry Catalysts: High Quality and Cost-Effective

    Jan 19, 2021, 11:34 AM by
    Full story
  • Data Analysis at MedAI: PrediXcan Based Analysis and BSLMM Prediction

    Jan 19, 2021, 11:34 AM by
    Full story
  • Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform

    Jan 19, 2021, 11:34 AM by
    Gut microbiota bioinformatics services help understand how the gut microbiota colonizes, varies and interacts with the host, and even how to associate with diseases can be of great value in the treatment of these diseases, such as inflammatory bowel disease (IBD), diabetes, mental disorders, and cancers.
    Full story
  • European Medicines Agency Selects Panalgo for Real-World Data Analytics

    Jan 19, 2021, 11:34 AM by
    Panalgo's IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
    Full story
  • Pronalyse Division Announced Vaccines Analysis Service to Ensure Vaccine Safety

    Jan 19, 2021, 11:34 AM by
    Pronalyse is dedicated to providing professional analysis services in biopharmaceutical development. Recently, the product manager has announced the vaccines analysis service to ensure the safety, efficacy, purity and potency of vaccine products.
    Full story
  • BioPure and Teknomek collaborate to deliver optimum workplace efficiency and hygiene confidence Status message

    Jan 19, 2021, 11:30 AM by
    Teknomek worked in collaboration with BioPure, taking account of employee welfare and clean room risk management, to create the ideal specification to support operational process and minimise risk.
    Full story
  • Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies

    Jan 19, 2021, 11:30 AM by
    These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.
    Full story
  • Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing

    Jan 19, 2021, 11:30 AM by
    Full story
  • ZEISS Announces Collaborative Research Partnership with Max Planck Florida Institute for Neuroscience

    Jan 19, 2021, 11:30 AM by
    The press release announces ZEISS has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI).
    Full story
  • ‘UK government can deliver Brexit benefit with world’s best medicines security’ say FarmaTrust

    Jan 19, 2021, 11:30 AM by
    Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system
    Full story
  • Samsung Biologics Shares ‘Vision’ for Next Decade at the 39th Annual JP Morgan Healthcare Conference

    Jan 19, 2021, 11:30 AM by
    Full story
  • The RSA Group welcomes Eleanor Davies as Managing Partner

    Jan 19, 2021, 11:29 AM by
    The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the appointment of a new senior team member. Eleanor Davies joins the company as Managing Partner.
    Full story
  • Jumpcode Genomics Secures $21M in Series B Funding

    Jan 19, 2021, 11:29 AM by
    Full story
  • Antibiotic Research UK announces the appointment of Mr. Simon Dukes as Chair Designate of the Board of Trustees

    Jan 19, 2021, 11:29 AM by
    Antibiotic Research UK is delighted to announce the appointment of Mr. Simon Dukes as Chair Designate of its Board of Trustees.
    Full story
  • «
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy